PH47

ICD-11 MMS 2026-01

Exposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs

Exclusions from above levels

  • http://id.who.int/icd/entity/1583926619 – Substances associated with injury or harm in therapeutic use

Child codes

  • PH47.0 – Exposure to or harmful effects of undetermined intent of mixed antiepileptics, not elsewhere classified
  • PH47.Z – Exposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs, unspecified

Sibling codes

  • PH40 – Exposure to or harmful effects of undetermined intent of opioids or related analgesics
  • PH41 – Exposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants
  • PH42 – Exposure to or harmful effects of undetermined intent of psychostimulants
  • PH43 – Exposure to or harmful effects of undetermined intent of cannabinoids or hallucinogens
  • PH44 – Exposure to or harmful effects of undetermined intent of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
  • PH45 – Exposure to or harmful effects of undetermined intent of antidepressants
  • PH46 – Exposure to or harmful effects of undetermined intent of antipsychotics
  • PH48 – Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances
  • PH49 – Exposure to or harmful effects of undetermined intent of multiple drugs, medicaments or biological substances

Foundation entity

Exposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs – http://id.who.int/icd/entity/37286776

Allowed postcoordination axes

Part of: 23: External causes of morbidity or mortality